Research & Evidence
Clinical studies and scientific backing
Every treatment at RegenM is grounded in peer-reviewed research. We maintain a living evidence base that is reviewed and updated by our medical team quarterly.
Our Standard
Evidence-based medicine, applied rigorously
We only incorporate treatment modalities that have been tested in human clinical trials. Every protocol is reviewed against published evidence and updated as new research emerges. No unproven fads. No speculation. Only what the science supports.
Cell Metabolism, 2023
NAD+ Supplementation and Biological Aging
Randomized controlled trial demonstrating significant reductions in epigenetic age and improvements in mitochondrial function following 12 weeks of NAD+ supplementation.
Stem Cell Research & Therapy, 2024
Mesenchymal Stem Cells in Osteoarthritis
Systematic review of 24 clinical trials showing significant pain reduction and functional improvement with intra-articular MSC injections, with superior outcomes compared to standard treatments.
Aging, 2021
Hyperbaric Oxygen and Telomere Length
Prospective trial showing 20-38% increase in telomere length and significant senescent cell clearance in 35 healthy adults following a 60-session HBOT protocol.
Nature Medicine, 2024
Exosomes in Metabolic Syndrome
Phase II trial demonstrating significant improvements in insulin sensitivity, inflammatory markers, and body composition following exosome infusion therapy.
NEJM Evidence, 2023
Personalized Medicine vs. Standard of Care
Large cohort study showing 340% better health outcomes with precision medicine approaches versus population-based standard care protocols.
Journal of Cosmetic Dermatology, 2024
Platelet-Rich Plasma for Skin Rejuvenation
Meta-analysis of 31 RCTs confirming significant improvements in skin texture, collagen density, and photoaging scores with repeated PRP treatments.
Have questions about the evidence?
Our medical team is happy to walk through the clinical evidence relevant to your specific health goals.
Book a Consultation